您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > AM 281
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
AM 281
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
AM 281图片
CAS NO:202463-68-1
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议

产品介绍
AM 281 是一种选择性 CB1 受体拮抗剂,IC50 为 9.91 nM。
Cas No.202463-68-1
别名1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺
化学名1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-morpholino-1H-pyrazole-3-carboxamide
Canonical SMILESIC1=CC=C(C=C1)C2=C(C)C(C(NN3CCOCC3)=O)=NN2C(C(Cl)=C4)=CC=C4Cl
分子式C21H19Cl2IN4O2
分子量557.22
溶解度≥ 1.86mg/mL in DMSO with ultrasonic and warming
储存条件Store at -20℃
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

AM 281 is a potent and selective antagonist/inverse agonist of CB1 cannabinoid receptor with Ki values of 12 and 4200 nM for CB1 and CB2 receptors, respectively [1].

CB1 cannabinoid receptor is a G protein-coupled receptor and is mainly expressed in the brain. Cannabinoid receptors play an important role in memory, mood, appetite and pain-sensation.

AM 281 is a potent and selective CB1 cannabinoid receptor antagonist/inverse agonist. In rat forebrain membranes, AM281 exhibited high affinity for CB1 receptor with Ki value of 12 nM. In mouse spleen membrane, AM281 exhibited very low affinity for CB2 receptor with Ki value of 4200 nM [1]. In mouse cerebellar homogenates, AM281 exhibited affinities for CB1 receptor with Ki values of 1.8, 2.8, 84, 208 and 2512 nM when competed with SR141716A, CP55,940, WIN 55,212-2, THC and methanandamide, respectively [2].

In morphine withdrawal mice, AM281 (2.5 mg/kg) significantly improved the memory impairment caused by morphine withdrawal [3].

References:
[1]. Lan R, Gatley J, Lu Q, et al. Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. AAPS PharmSci, 1999, 1(2): E4.
[2]. Gatley SJ, Lan R, Volkow ND, et al. Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo. J Neurochem, 1998, 70(1): 417-423.
[3]. Vaseghi G, Rabbani M, Hajhashemi V. The CB(1) receptor antagonist, AM281, improves recognition loss induced by naloxone in morphine withdrawal mice. Basic Clin Pharmacol Toxicol, 2012, 111(3): 161-165.